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A completely automatic computerized technique for the quantita-
tive estimation of the deamidation rates of any protein for which
the three-dimensional structure is known has been developed.
Calculations of the specific deamidation rates of 170,014 asparag-
inyl residues in 13,335 proteins have been carried out. The calcu-
lated values have good quantitative reliability when compared
with experimental measurements. These rates demonstrate that
deamidation may be a biologically relevant phenomenon in a
remarkably large percentage of proteins.
asparaginyl residue deamidation  coefficient of deamidation  deamidation
index
Changes in peptide and protein structure through the spon-taneous nonenzymatic deamidation of glutaminyl and as-
paraginyl residues have been observed in many in vitro and in vivo
experiments. Rates of deamidation of individual amide residues
depend upon primary sequence, three-dimensional (3D) struc-
ture, and solution properties such as pH, temperature, ionic
strength, and buffer ions (1–8).
Deamidation at neutral pH introduces a negative charge at the
deamidation site and sometimes also leads to  isomerization.
These alterations in structure affect the properties of peptides
and proteins in chemically and biologically important ways. It has
been suggested that in vivo deamidation of proteins serves as a
molecular timer of biological events and as a mechanism for
postsynthetic production of unique proteins of biological signif-
icance (2, 4, 6, 7, 9, 10). In the case of in vivo protein turnover,
the use of deamidation as a molecular timer has been experi-
mentally demonstrated (11–13).
Progress in the understanding of deamidation and its potential
biological importance has been impeded by the lack of reliable
and useful experimental and theoretical information about the
deamidation of most proteins. Experimental studies of the
deamidation of individual proteins are laborious and time con-
suming. Until recently, there were no other means by which to
estimate the deamidation rates of specific amides.
The deamidation rates of individual Asn residues in a protein
can now be reliably predicted as a result of two recent advances.
First, the sequence-controlled Asn deamidation rates of most of
the 400 possible near-neighbor combinations in pentapeptide
models have been measured (10); the deamidation rates of a
representative group of Gln pentapeptides have been deter-
mined (N.E.R. & A. B. Robinson, unpublished work); and the
relevance of these rate libraries has been established (14).
Second, these rates and the 3D structures of proteins with well
characterized deamidations have been combined to produce a
computation method that correctly predicts the deamidation
rates of most Asn residues for which the 3D structure is known
(15). This method has been shown to be 95% reliable in
predicting relative deamidation rates of Asn residues within a
single protein, and it is also useful for the prediction of absolute
deamidation rates. It has been used to estimate the deamidation
rates of 1,371 asparaginyl residues in 126 human proteins (16).
This semiempirical method for estimating deamidation rates
(15) depends, however, upon manual observations of a set of 3D
characteristics of the protein structure near each amide residue
in the protein. These observations are laborious and subject to
human error. In using this method, approximately 4 h of work by
an experienced investigator with a computer-based 3D-structure
viewer is required to determine the deamidation rates of the
amides in a typical protein.
The computerized deamidation estimation method reported
herein automatically determines essentially the same 3D char-
acteristics as the manual method, with some significant refine-
ments. It is, however, much faster, more reliable, and more
convenient. During 4 h of continuous computation with a
Pentium IV computer, the deamidation rates for the entire
Brookhaven 3D protein database of 13,335 amide-containing
protein structures with 170,014 asparaginyl residues have been
calculated by this technique. These estimated deamidation rates,
which include all amide-containing protein structures in the
Brookhaven Protein Data Bank as of April 2001, have been
deposited at www.deamidation.org. The computer program is
also freely available at this Internet site, so investigators can
compute these values for additional proteins.
These calculations provide new insights into the nature of
protein deamidation. Moreover, this new method contains sub-
routines for automatic refinement of the calculation procedure
as new experimental deamidation rates become available and
also allows automatic calculation of additional estimated protein
deamidation rates as new 3D structures are determined.
Materials and Methods
Calculation Method. Deamidation coefficients (CD) for individual
amides and deamidation indexes (ID) for individual proteins
were determined by a fully computerized procedure similar to
the manual technique reported (15). Some parts of the calcu-
lation method were refined, and all of the adjustable parameters
were automatically optimized. The computer program was writ-
ten with Microsoft C. The program uses Swiss Protein Data
Bank Viewer to detect -helices and -sheets. The calculations
were made by means of a Pentium IV computer with Microsoft
WINDOWS 2000.
The deamidation coefficient, CD, is defined as CD  (0.01)
(t1/2)[ef(Cm,CSn,Sn)], where t1/2 is the primary structure half-life
(10, 14), Cm is a structure proportionality factor, CSn is the 3D
structure coefficient for the nth structure observation, Sn is that
observation, and f(Cm,CSn,Sn)  Cm[(CS1)(S1)  (CS2)(S2) 
(CS3)(S3)  (CS4,5)(S4)(S5)  (CS6)(S6)  (CS7)(S7)  (CS8)(S8)
 (CS9)(S9)  (CS10)(1  S10)  (CS11)(5  S11)  (CS12)(5 
S12)]. The structure observations, Sn, are those that impede
deamidation, including hydrogen bonds, -helices, -sheets, and
peptide inflexibilities.
For Asn in an -helical region:
S1 distance in residues inside the -helix from the NH2 end,
where S1  1 designates the end residue in the helix, 2 is the
second residue, and 3 is the third residue. If the position is 4 or
greater, S1  0.
S2  distance in residues inside the -helix from the COOH
end, where S1 1 designates the end residue in the helix, 2 is the
Abbreviations: 3D, three dimensional; ID, deamidation index; CD, deamidation coefficient;
Dp, deamidation resolving power.
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second residue, and 3 is the third residue. If the position is 4 or
greater or S1  0, then S2  0.
S3  1 if Asn is designated as completely inside the -helix
because it is 4 or more residues from both ends. If the Asn is
completely inside, S3  1, S1  0, and S2  0. If S1  0 or S2 
0, then S3  0.
For flexibility of a loop including Asn between two adjacent
anti-parallel -sheets:
S4  number of residues in the loop. If the flexible region is
not bounded on both sides by -sheets with at least four
hydrogen bonds between opposite NH and CO groups, then
this parameter is not used, so S4  0.
S5  number of hydrogen bonds in the flexible region  1.
For hydrogen bonds:
S6 the number of hydrogen bonds to the Asn sidechain CO
group. Acceptable values are 0, 1, and 2. Hydrogen bonds that
are used in S8 are not counted.
S7 the number of hydrogen bonds to the Asn sidechain NH2
group. Acceptable values are 0, 1, and 2.
S8  the number of hydrogen bonds to the backbone N in the
peptide bond on the COOH side of Asn. Acceptable values are
0 and 1. This nitrogen is used in the five-membered succinimide
ring intermediate.
S9  the number of other hydrogen bonds that need to be
broken to form the succinimide ring. The number of these bonds
is estimated by first determining the angle through which the
amide residue bond between the  carbon and the backbone
carbonyl carbon would need to be rotated to align the backbone
in the optimum configuration for forming the succinimide ring.
This angle is then divided by 180° to give a number R between
0 and 1, where 0 is perfectly aligned and 1 is the worst alignment,
requiring the greatest change in backbone position.
Residues that require greater chain movement to deamidate
usually must break hydrogen bonds farther from the amide
residue, so all hydrogen bonds are counted that are less than
(R)(CR) from the C of the amide residue to either hydrogen
bond atom and that are no more than five residues along the
chain from the amide. The value of CR was optimized at 4.97 Å.
Hydrogen bonds that are counted in S6, S7, or S8 are excluded
from S9.
For Asn situated so that no -helix, -sheet, or disulfide bridge
structure is between the Asn and the end of the peptide chain,
and the Asn is 20 residues or less from the chain end:
S10  1 if the number of residues between the Asn and the
nearest such structure is 3 or more. If the number of intervening
residues is 2, 1, or 0, or if the Asn is not between a structure and
the chain end, then S10  0. This parameter accounts for extra
flexibility of the protein chain near the end. It is assumed that,
in addition to the factors specifically included in these Sn,
residues in the middle of proteins are additionally restrained, and
that this part of the restraint is removed for amides near the end
of the chain.
If the Asn lies near in sequence to any -helix, -sheet, or
disulfide bridge structures:
S11  the number of residues between the Asn and the
structure on the NH2 side, up to a maximum of 5. Values of 0,
1, 2, 3, 4, and 5 are acceptable.
S12  the number of residues between the Asn and the
structure on the COOH side, up to a maximum of 5. Values of
0, 1, 2, 3, 4, and 5 are acceptable.
Hydrogen bonds between the usual atoms were assumed if the
bond length was 4.1 Å or less, and the angle of the hydrogen bond
was no more than 180° greater than the optimum nor 55° less
than the optimum. This 4.1 Å value was determined by optimi-
zation and is greater than normally accepted for a hydrogen
bond. The extra length may be caused by hydrogen-bond inter-
actions that occur at different times because of flexibility in the
protein. In most cases, the protein backbone must move to some
extent to form the succinimide ring. If hydrogen bonds were
assigned beyond the space available to accommodate the van der
Waals radius of all of the hydrogen atoms, then the surplus bonds
were rejected. For these rejections, the longest bonds with the
most strained angles were removed.
X-ray crystal structures do not usually give hydrogen atom
positions. For consistency, therefore, the hydrogen atom coordi-
nates in NMR and neutron diffraction structures were not used.
The presence of hydrogen atoms was assumed wherever
hydrogen atoms are ordinarily found in protein structures. In
some cases, particularly –OH and –NH2 groups, the orientation
of the hydrogen atoms is uncertain. It was assumed that they
would be positioned, where possible, to form the best hydrogen
bonds.
The number of hydrogen atoms and donor groups available
limits the number of hydrogen bonds. For example, an –OH
group cannot have more than one hydrogen bond with atoms
that are only hydrogen-bond acceptors. In cases where more than
one donor or acceptor was available for forming a particular
hydrogen bond, the one with the best characteristics was chosen.
This choice involved a compromise between the optimum bond
angle and optimum bond length.
All primary structure t1/2 values used were those published (10,
14), except for sequences that have not been experimentally
measured. Those included Asn with carboxyl-side Pro, Asn, Gln,
or residues that are not among the ordinary 20, Asn without a
free amide as a result of binding to metals or other moieties, and
other unusual sequences. Estimates of t1/2 values for these were
approximated from those measured (10, 14).
The approximated values were: Asn-Pro, 500; Asn-Hyp, 500;
Asn-Asn, 40; Asn-Gln, 60; bound Asn, 500; Asn-Xxx, where Xxx
is carboxyl terminal, 12 of pentapeptide value; Yyy-Asn-Xxx,
where Yyy is not one of the ordinary 20 amino acid residues but
is instead Mse, Ini, Llp, Pca, Cgu, Tyq, Tyy, Tpq, Cea, or Cme,
mean value for the ordinary amino acids at Yyy (10); Yyy-Asn-
Xxx, where Xxx is Tyq, Tyy, or Tpq, same value as for Tyr; Xxx
is Cea or Cme, same value as for Cys; where Xxx is Ini, same
value as for Arg; Asn as carboxylamide terminal, 40; Asn as
carboxyl terminal, 500; Asn as amino terminal, 23 pentapeptide
values; and Xxx-Asn-Mse, 43 Met value.
Structures for 22 proteins from the Brookhaven Protein Data
Bank combined with their relative Asn instabilities (15, 16) were
used in the optimization of the coefficients Cm and CSn. These
structures included all of the Asn residues in rabbit aldolase
chain A, 1ADO; human angiogenin chain A, 1B1I; pig c-amp-
dependent protein kinase chain A and chain I, 1CDK; mouse
epidermal growth factor, 1EGF; rat fatty acid binding protein,
1LFO; human fibroblast growth factor chain A, 2AFG; Aspergil-
lus awamorii glucoamylase, 3GLY; human growth hormone,
IHGU; 1HGU; Escherichia coli hpr-phosphocarrier protein,
1HDN; human insulin chain A and chain B, 2HIU; mouse
interleukin 1, 2MIB; chicken lysozyme chain A, 1E8L; bovine
ribonuclease A chain A, 1AFK; Ustilago sphaerogena ribonucle-
ase U2, 1RTU; bovine seminal ribonuclease chain A, 11BG;
human thioltransferase, 1JHB; human triosephosphate isomer-
ase chain A, 1HTI; bovine trypsin, 1MTW; bovine DNase chain
A, 2DNJ; and human vascular endothelial growth factor chain A,
2VPF. Horse heart cytochrome c (2GIW) was used, except for
Lys-Asn 54-Lys, which is reported to be accelerated by a 3D
structure change caused by an earlier single deamidation (11,
12). No 3D structure is available for this singly deamidated form.
Human hypoxanthine guanine phosphoribosyltransferase chain
A (1BZY) was used except for Lys-Asn 106 Asp, which is held
by 3D structure in exact position for the succinimide interme-
diate in the deamidation reaction and is, therefore, accelerated.
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The coefficients Cm and CSn were optimized by means of the
deamidation resolving power (Dp) method (15, 17). The opti-
mized values were Cm  0.48, CS1  1.0, CS2  3.1, CS3  10,
CS4,5  1.5, CS6  0, CS7  0.5, CS8  3.2, CS9  1.9, CS10  2.0,
CS11  0.26, and CS12  0.62. The DP was found to be 96.5%.
The protein deamidation index is defined as ID 
[(CDn)1]1, where CDn is CD for the nth Asn residue. There-
fore, (100)(ID) is an estimate of the initial deamidation halftime
for the protein with all Asn residues considered.
The coefficients of deamidation, CDn, and deamidation index,
ID, for each protein were calculated by means of computer
programs that are available for use at www.deamidation.org.
These can be used for any new protein in the following way.
Primary sequence data for the protein in the format of the
‘‘SEQRES’’ section of the Brookhaven Protein Data Bank and
3D data—including the x, y, and z coordinates for each atom—in
the format of the ‘‘ATOM’’ and ‘‘CONECT’’ sections of
Brookhaven Protein Data Bank are automatically computer-
entered into the program. No manual entry of data are required.
Note that if no coordinates are entered for the atoms of a
particular residue, it is assumed that this residue is unrestrained
and does not participate in a unique 3D structure, which can
modulate deamidation. After the data are entered, the computer
program calculates the CDn and ID values for the protein. The
program output includes these values and also the values of Sn
for each amide residue, so that the investigator can know the
details about the calculation of CDn for each amide.
This calculation method is conceptually general. The molec-
ular rearrangements necessary for formation of a cyclic deami-
dation intermediate are usually impeded by protein structure.
Those structural impediments have been parameterized. The
success of the method does not, however, prove the cyclic imide
reaction mechanism, because other mechanisms may be similarly
impeded.
Only relative deamidation rates, in the form of reports about
which amides have been observed to be deamidated in 22
proteins under a wide variety of conditions, have been used to
calibrate the method by optimizing the coefficients, Cm and CSn.
No rate measurements were used for the optimization. Rate of
deamidation measurements in 13 proteins at 37°C were used only
to test and verify the method (16). Nine of these 13 proteins are
in the set of 22 coefficient calibration proteins, and 4 are not.
At no time in its development was this calculation method
adapted to any specific aspect of the structures of these 26
individual proteins. The method fails, therefore, for Asn-106 of
human hypoxanthine guanine phosphoribosyltransferase chain
A, which is a rare example in which deamidation is actually
accelerated by 3-D structure. In this case, Asn-106 is held by 3-D
structure in exactly the correct position for the deamidation
reaction, so the reaction is enhanced. Although a term could be
added to the calculation method to allow for this, it would detract
from the generality of the method, and Asn-106 is the only case
of this type presently known.
Results and Discussion
The most important results of this work are in the estimated
deamidation rates of individual proteins. These calculations
provide reliable estimates of instability with respect to deami-
dation for the Asn residues in all of the amide-containing
proteins in the Brookhaven protein 3D structure database and
are easily performed for any other protein for which a 3D
structure becomes available.
In addition, these calculations provide some general insights
about deamidation and its prevalence in proteins, as illustrated
in Fig. 1, Fig. 2, Fig. 3, Table 1, and Table 2.
These estimated deamidation rates depend upon peptide rates
that were experimentally determined in pH 7.4, 37°C, 0.15 M
TrisHCl buffer and upon calculations that estimate the relative
contributions of primary and 3D structure. Therefore, the
estimated deamidation rates are for pH 7.4, 37°C, 0.15 M
TrisHCl buffer. These baseline solution conditions were chosen
because Tris catalyzes deamidation to a much lesser extent than
most other buffers. Phosphate buffers and the solute mixtures
typically found in living things usually increase deamidation rates
at least two or three-fold as compared with those in Tris (16).
The deamidation halftimes shown in Figs. 1 and 2 are, thus,
longer than those expected in living things at 37°C.
Fig. 1a shows the cumulative distribution function of the
estimated first-order deamidation rate constants in 131,809
asparaginyl residues in 10,369 proteins, whereas Fig. 1b shows
the derivative of the function in 1a, with the unusually unstable
amides illustrated. For these figures, 2,966 redundant protein
Fig. 1. (a) Cumulative distribution function of the calculated first-order rate
constants for deamidation of the 131,809 Asn residues in 10,369 proteins used
in Table 1. Asn residues involved in the initial deamidation of these proteins
are a relatively small part of the complete set. The computed percentage of
the Asn residues that are 110 deamidated after 10 days in pH 7.4, 37°C, 0.15
M TrisHCl is 4%, as shown. (b) Differentiated values of the distribution
function in a showing the special class of unstable Asn residues present in
these proteins. Also shown with a red line is a Gaussian function that fits the
distribution function, except for that part arising from the especially unstable
Asn residues. The shaded area contains those Asn residues computed to be
110 or more deamidated in 10 days in pH 7.4, 37°C, 0.15 M TrisHCl.








structures in the Brookhaven Protein Data Base have been
excluded. These curves and those for human proteins (16) are
qualitatively and quantitatively similar. In the course of this
work, these functions also have been calculated for mouse, rat,
chicken, Bacillus subtilis, and Escherichia coli proteins. Although
not identical, these distributions are all quite similar, with mouse,
B. subtilis, and E. coli having somewhat higher numbers of
unstable amides in their proteins as compared with human, rat,
and chicken.
As has been reported for human proteins (16), deamidation is
not a random consequence of the presence of Asn residues in
proteins. The fast deamidations summarized in Fig. 1 result from
a set of Asn residues with unusual primary and 3D structures,
which comprise about 5% of the total. These need not have been
incorporated in protein structures, because most individual Asn
deamidation rates are slower.
Whereas both the amino side and carboxyl side residues
immediately adjacent to the amide residues affect deamidation
rates, the carboxyl side residue is more important (10). Asn
deamidation at neutral pH has been reported to proceed pri-
marily by means of a succinimide mechanism, which involves an
intermediate ring structure on the carboxyl side of the deami-
dating residue (18–20). Fig. 2 illustrates the relative importance
of the different carboxyl side residues as a function of protein
deamidation halftime. Although there are rare reported in-
stances of 3D structures that increase deamidation rates, most
rates are determined by primary structure as modulated through
slowing by 3D structure. Therefore, only Asn-Gly sequences in
locations that are relatively sterically unhindered provide Tris
deamidation halftimes of less than about 6 days. Most Asn-Gly
sequences have longer halftimes because of 3D effects.
Primary structure deamidation rates in Tris for Asn-His,
Asn-Ser, and Asn-Ala peptide sequences range from 6 to 32 days
(10, 14), so these sequences and additional, more hindered
Asn-Gly sequences dominate this deamidation halftime range
and that immediately higher. Within 100-day halftimes, all other
sequences except for Asn-Leu, Asn-Val, Asn-Ile, and Asn-Pro
significantly contribute. The estimated deamidation halftimes
between 100 and 10,000 days are qualitatively and semiquanti-
tatively useful, but these rates lack the direct experimental
verification available for the shorter halftimes (16). Other pro-
cesses such as additional deamidation mechanisms, side chain
oxidation, peptide bond cleavage, and racemization also become
more important at the longer time intervals. These deamidation
Fig. 3. Deamidation resolving power, Dp vs. 3D structure coefficient Cm for
192 Asn residues in 22 proteins. The optimum value of Cm 0.48 provides the
most reliable estimated relative deamidation rates as compared with the
experimental values for these proteins.









Tris 12 time, days
1 20 0.02 0.19
2.5 162 0.12 1.5
5 473 0.36 3.7
10 695 0.53 5.6
25 1659 1.3 13
50 3591 2.7 25
100 7080 5.4 41
Phos. 110 time, days
1 538 0.41 4.3
2.5 1101 0.84 8.8
5 2208 1.7 17
10 5029 3.8 32
25 10798 8.2 52
50 16340 12 64
100 23652 18 75
Fig. 2. Percentage of deamidating amides of the 131,809 Asn residues in
10,369 proteins used in Table 1 vs. deamidation half-time for Asn-Gly se-
quences; Asn-His, Asn-Ser, and Asn-Ala sequences; all sequences other than
Asn-Gly, Asn-His, Asn-Ser, Asn-Ala, Asn-Leu, Asn-Val, and Asn-Ile; and Asn-
Leu, Asn-Val, and Asn-Ile sequences. As deamidation halftime increases, more
sequences contribute to deamidation. Except for a small number of especially
sterically unhindered Asn residues, these deamidation halftimes strongly
depend upon primary and 3D structures. These values are estimated for pH 7.4,
37°C, 0.15 M TrisHCl and would be faster in vivo at 37°C.
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halftimes are likely to be at least 2- to 3-fold shorter in biological
systems at 37°C (16).
Each of the curves in Fig. 2 contains a subgroup of amides that
are close to the ends of the proteins. These subgroups arise from
Asn sequences with relatively short deamidation halftimes, as a
result of their positions near the ends of protein chains, where
they are largely free of constraining 3D effects. The Asn residues
that have been reported to control the turnovers of rat cyto-
chrome c (11, 12) and rabbit muscle aldolase (13) are of this type.
In both of these cases, there is marked preferential in vivo
degradation of the deamidated protein molecules. Because the
estimated range of Asn deamidation halftimes available in these
subgroups is between 0.2 days and more than 200 days under
most in vivo conditions at 37°C, and they are free of 3D
constraints, this type of Asn residue is especially well suited for
biological purposes.
Fig. 3 illustrates, by means of the parameter Cm, the optimi-
zation routines that were used for all of the parameters in these
calculations. By using the deamidation resolving power tech-
nique (15, 17), all suitable and published experimental relative
deamidation observations of proteins are used to optimize each
adjustable 3D parameter. The relative proportions of primary
and 3D structure effects are determined by optimization of the
illustrated parameter Cm as shown in Fig. 3. At the optimum
value of Cm  0.48, the experimental deamidation rates are
96.5% correctly ordered by the calculations. The remaining 4%
of disorder includes amides wherein the inhibitory effects of 3D
structure are imperfectly estimated by this calculation method
and those where the experiments themselves are in error.
Moreover, most of the deamidation rates of the imperfectly
ordered 4% of Asn residues are estimated approximately
correctly.
Optimization of the deamidation resolving power at 96.5%
requires both primary and 3D structure. When primary structure
alone is used, Dp  79.8%. With 3D structure alone, Dp 
64.3%.
Table 1 shows the percentages of 131,809 asparaginyl residues
in 10,369 proteins with 37°C Tris buffer and phosphate buffer
deamidation halftimes in various ranges and the percentages of
proteins with at least one amide with a deamidation halftime
within those ranges. Phosphate is a stronger catalyst of deami-
dation than is Tris (6, 7, 16, 21). The phosphate deamidation
halftimes are estimated for Table 1 as 12 the Tris halftimes (16).
Under in vivo conditions at 37°C, deamidation halftimes would
be expected to be, on average, even shorter than those estimated
in Table 1 for phosphate (16). As shown, about 17% of all
proteins are estimated to have at least one amide that is 110 or
more deamidated after 5 days in phosphate at 37°C. Approxi-
mately 4.3% are 110 or more deamidated after 1 day. At 37°C
in vivo, these percentages are expected to be higher (16).
Accelerated protein turnover of deamidated forms and other
factors can obscure the observation of these deamidations in
ordinary experiments on protein preparations extracted from
living things.
Table 2 provides quantitative summaries for 131,809 specific
Asn-Xxx sequences. For example, Table 2 shows that 12% of all
Asn-His sequences are estimated to be at least 110th deami-
dated after 25 days in 37°C phosphate buffer. In addition to these
values, Table 2 also illustrates that it is not possible to usefully
determine the relative deamidation rates of specific amides
within a protein on the basis of primary sequence alone.
Whereas the effects of primary sequence are evident, even in the
simplest case of Asn-Gly, most deamidation halftimes are sub-
stantially determined by a combination of primary and 3D
structure.
The calculations reported herein include only Asn residue
deamidation. The rates of deamidation of glutaminyl residue,
Gln, containing pentapeptides have recently been determined
for a set of 60 Gln peptides with a representative range of
sequences (N.E.R. & A. B. Robinson, unpublished work). Gln
deamidation, like Asn deamidation, depends strongly upon the
residue on the carboxyl side of the amide, with Gln-Gly being the
fastest to deamidate. Deamidation halftimes for Gln-Gly se-
quences in pH 7.4, 37°C, 0.15 M TrisHCl buffer are in the range
of 400–600 days (N.E.R. & A. B. Robinson, unpublished work).
The values for other sequences are substantially longer. Amino
terminal Gln is, however, expected to deamidate more rapidly to
the pyrrolidone. Gln residues do not, therefore, significantly
affect most of the deamidation index calculations reported
herein. As with Asn, Gln deamidation is accelerated by phos-
phate buffer (5, 6).
Gln deamidations over periods of many years in vivo in
slow-turnover proteins of long-lived organisms such as human
eye lens proteins (22) can be of substantial biological signifi-
cance. Gln-Gly sequences in sterically unhindered locations of
proteins that lack shorter-lived Asn residues also affect the
deamidation index. Where buffer ion or other deamidation
catalysts are present, Gln deamidation can be more significant.
Deamidation is currently being experimentally studied in many












Gly 4.2 6.0 11 38
His 0.46 2.4 7.7
















Gly 14 27 53 87.3
His 3.6 5.9 12 33.2
Ser 2.9 8.1 14 34.6
Ala 1.9 4.2 7.2 17.9
Cys 0.23 0.84 2.6 7.3
Thr 0.14 1.5 4.2 12.3
Asp 0.93 1.9 6.8 19.0
Lys 0.071 1.2 4.4 10.4
Glu 0.057 1.6 5.3 13.1
Gln 0.041 1.4 3.9 10.1
Arg 0.035 1.0 3.4 9.4
Asn 0.15 1.4 5.0 13.5
Phe 0.46 2.3 7.3
Met 0.036 0.75 2.4 5.4
Tyr 0.038 0.36 1.2 5.4
Trp 0.16 0.74 5.0
Leu 0.26 1.3 5.4
Val 0.01 2.80
Ile 0.013 1.3








proteins under in vivo and in vitro circumstances. For examples,
see refs. 21–25.
Conclusions
Experimental (10, 14) and semiempirical computational (15, 16)
advances have made possible reliable estimates of the deamida-
tion rates of asparaginyl residues in proteins under biologically
relevant conditions. These estimates, which require knowledge
of the 3D structure of each molecule, are in accord with the
known in vivo and in vitro experimental data and have been
previously applied to 126 proteins of human origin (16).
It is reported herein that this method for estimating deami-
dation rates (15) has been fully computerized, further refined,
and completely applied to the entire 170,014 Asn residues of the
13,335 amide-containing protein structures in the Brookhaven
Protein Data Bank of 3D structures as of April 2001. These
computed deamidation rates are available on the Internet at
www.deamidation.org.
These calculation procedures make possible further refine-
ments in the adjustable parameters, as more experimental data
becomes available. Fully automatic deamidation estimates for
additional proteins also may be made, as their 3D structures are
determined. With the computer programs now freely available
on the Internet at www.deamidation.org, an investigator can
automatically enter the standard sequence and 3D parameters
for any protein and calculate the deamidation coefficients and
deamidation index for that protein.
The estimated deamidation rates apply directly to pH 7.4,
37°C, 0.15 M TrisHCl buffer. Deamidation proceeds at a
minimal rate under these conditions. There are no reported
experimental deamidation rates at 37°C that are not the same as
or faster than these computed Tris rates (16). The range of
reported experimental values at 37°C is between the Tris rates
and about 3-fold faster, depending upon solvent conditions. The
average is about 2-fold faster.
The computed rates show that significant amounts of deami-
dation may be expected to occur in a substantial percentage of
proteins under physiological conditions. Deamidation can con-
trol in vivo protein turnover. This result was found to be the case
in cytochrome c (11, 12) and in rabbit muscle aldolase (13,
26, 27).
Many other biological processes such as homeostasis, devel-
opment, and aging require timers, which are, as yet, unknown.
Because protein deamidation rates can be genetically pro-
grammed throughout the range from a few hours to hundreds of
years, and the deamidation rates found in proteins include many
that are within the biologically significant range, deamidation is
a good candidate for the timing of many biological processes.
Deamidation also provides a means of producing postsynthetic
varieties of proteins that are biologically useful and of timing
their release into in vivo systems.
Moreover, intermolecular effects resulting from in vivo pro-
tein locations such as in aggregates, membranes, and other
organelles can further enhance the versatility exhibited herein in
the intramolecular control of deamidation. A possible example
of this has been reported for cytochrome c (6, 12).
Proteins contain amide residue clocks. These residues are
found in almost all proteins, and amide residue clocks are found
to be set to timed intervals of biological importance, even though
settings to longer times are not only available, but also make up
most of the genetically available settings. Deamidation changes
protein structures in fundamentally important ways. If deami-
dation were not of pervasive and positive biological importance,
these clocks would have been set to time intervals that are long
with respect to the lifetimes of living things. The fact that they
are found to be set instead to biologically relevant time intervals
strongly supports the original hypothesis (2, 4, 6, 7, 9, 10) that
amides play, through deamidation, a special biologically impor-
tant role.
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